Definitive Healthcare Corp. (Class A) (DH) Dividend Safety Gauge & 10-Year DRIP Compounder

Per the Roarable RQD rating, DH scores 48 out of 100, grade D, labeled "Roarable Sell — Underperform / Distribution Warning." The five pillars are:

• Fundamental Cash Engine: 4 / 20. Per the RQD rating, ROIC is -35% and FCF yield is 22.82%. For a prospective investor, the weak ROIC indicates the company is not currently earning returns on invested capital, while the high FCF yield is a positive cash-generation signal that the rating weighs only lightly against the profitability deficit.
• Whale 13F Flow: 11 / 20. The rating reflects institutional accumulation and options positioning at a moderate level. Holder-level detail is not available in source data, so the specific direction of institutional flows cannot be confirmed here.
• Insider Conviction: 11 / 20. The rating reflects SEC Form 4 and Congressional PTR cluster flow at a moderate level. Individual transaction records are not available in source data.
• Macro Regime Fit: 12 / 20. Per the RQD rating, beta is 1.0 and the score reflects sector sensitivity. A beta of 1.0 implies market-level sensitivity to broad moves, which means DH's price may track the overall market rather than offering defensive or differentiated behavior.
• Forensic Balance Sheet: 10 / 20. Per the RQD rating, Altman Z is 0.2, Piotroski F is 7/9, and Debt/Equity is 0.41. The low Altman Z is a distress-zone signal, partly offset by a relatively strong Piotroski reading and moderate leverage.

Taken together, the rating points to a stock whose cash generation and balance sheet mix is the most mixed element, while profitability and distress metrics weigh heavily on the overall score. A prospective investor should treat the Roarable rating as an analytical framework that summarizes these tradeoffs, not as a recommendation to buy or sell.

Definitive Healthcare Corp. (Class A) is a NASDAQ-listed issuer in the Technology sector, operating in the Computer Software: Prepackaged Software industry, per the company profile. The source data does not describe its specific products, customer base, or revenue model. Per the market data, gross margin is 75.9%, indicating a high-margin software revenue profile, though the source data does not confirm the underlying business mechanics.

Per the SEC financials, revenue has been broadly flat across the three reported years, moving from $251.4M to $252.2M to $241.5M, while operating and net losses have been substantial in each period. Per the market data, operating margin is -60%, net margin is -57.5%, and ROIC is -35%. The RQD rating reports an Altman Z-Score of 0.2 and a Piotroski F-Score of 7/9, and a Debt/Equity ratio of 0.41. Reported cash rose from $105.4M in FY 2024 to $163.6M in FY 2025, while debt declined from $229.4M to $156.1M over the same period.

Per the recent news and catalysts section, the most recent items are largely market-wire and aggregator reports. One item is flagged as a CATALYST and concerns Simply Wall St coverage of Veeva Systems and IQVIA; this relates to a peer rather than to DH directly. A TradingView item cites a Q3'26 revenue estimate of 54.57M USD for DH. A Stock Titan item reports that a legal chief received 864,534 shares following tax withholding. The remaining items are generic market-activity and positioning summaries with no company-specific detail. Per the Butterfly Supply-Chain Graph, no supply-chain links or proprietary signals are recorded for DH.

Per the Butterfly Supply-Chain Graph, the supply chain is recorded as NONE, with no butterfly links and no proprietary signals. The source data therefore does not identify upstream suppliers, downstream customers, or sector correlations. Based strictly on the sector and industry classification, the peer references in the news wire (Veeva Systems and IQVIA) are the only related names mentioned, and the source data does not describe the nature of any dependency. A prospective investor should watch for any future disclosure of customer concentration or supplier dependency, though none is available in the current source data.

• What are the company's specific products, customers, and revenue model, given that the source data describes only the sector and industry?
• What drove the FY 2024 operating loss of $-710.8M, and what portion is non-recurring versus ongoing?
• Why are FY 2025 and FY 2024 EPS values listed as N/A, and what is the share count underlying the $162.4M market capitalization?
• What is the cash burn and liquidity runway, given Altman Z-Score of 0.2 and the reported cash and debt levels?
• What does the $0.61 to $3 52-week range reflect in terms of company-specific events?